Eli Lilly and Co LLY

NYSE US Health Care Pharmaceuticals

$1,148.84 ▼ -0.53% ($-6.13)

Index member: S&P 500

⬇️ Below Yest. Low 📅 Earnings This Week

Open $1,148.51

Prev Close $1,154.97

Day Range $1,119.00 – $1,150.63

52W Range $623.78 – $1,249.45

Market Cap $1.08T

P/E (TTM) 42.57

Beta 0.51

Div Yield 0.60%

EPS (TTM) $28.15

📋 Company Profile

Industry	Pharmaceuticals
Sector	Health Care
Country	US
Exchange	NEW YORK STOCK EXCHANGE, INC.
Currency	USD
IPO Date	1970-07-09
Shares Out.	941,740,000
Website	lilly.com/ ↗
Phone	13172762000
Employees	50,000
Revenue	$19.80B
Gross Profit	$16.22B
Net Income	$7.40B
Free Cash Flow	$11.82B
Total Assets	$116.58B
Total Liabilities	$85.38B
Equity	$31.20B

About Eli Lilly and Co

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Eli Lilly and Co is a publicly traded company under the ticker symbol LLY on the NEW YORK STOCK EXCHANGE, INC., operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.